These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 10192273

  • 1. Timing: A critical determinant of the functional consequences of neonatal 6-OHDA lesions.
    Neal-Beliveau BS, Joyce JN.
    Neurotoxicol Teratol; 1999; 21(2):129-40. PubMed ID: 10192273
    [Abstract] [Full Text] [Related]

  • 2. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
    Neal-Beliveau BS, Joyce JN.
    Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220
    [Abstract] [Full Text] [Related]

  • 3. There is a limited critical period for dopamine's effects on D1 receptor expression in the developing rat neostriatum.
    Thomas WS, Neal-Beliveau BS, Joyce JN.
    Brain Res Dev Brain Res; 1998 Nov 01; 111(1):99-106. PubMed ID: 9804909
    [Abstract] [Full Text] [Related]

  • 4. Ontogenetic quinpirole treatments fail to prime for D2 agonist-enhancement of locomotor activity in 6-hydroxydopamine-lesioned rats.
    Brus R, Kostrzewa RM, Nowak P, Perry KW, Kostrzewa JP.
    Neurotox Res; 2003 Nov 01; 5(5):329-38. PubMed ID: 14715452
    [Abstract] [Full Text] [Related]

  • 5. Neonatal 6-OHDA lesions differentially affect striatal D1 and D2 receptors.
    Neal BS, Joyce JN.
    Synapse; 1992 May 01; 11(1):35-46. PubMed ID: 1351321
    [Abstract] [Full Text] [Related]

  • 6. Neonatal 6-hydroxydopamine lesions lead to opposing changes in the levels of dopamine receptors and their messenger RNAs.
    Frohna PA, Neal-Beliveau BS, Joyce JN.
    Neuroscience; 1995 Sep 01; 68(2):505-18. PubMed ID: 7477961
    [Abstract] [Full Text] [Related]

  • 7. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
    Pollack AE, Yates TM.
    Neuroscience; 1999 Sep 01; 94(2):505-14. PubMed ID: 10579212
    [Abstract] [Full Text] [Related]

  • 8. Stimulation of D1- or D2-receptors in drug-naive rats with different degrees of unilateral nigro-striatal dopamine lesions.
    Fornaguera J, Huston JP, Carey RJ, Schwarting RK.
    Psychopharmacology (Berl); 1995 May 01; 119(2):145-54. PubMed ID: 7659761
    [Abstract] [Full Text] [Related]

  • 9. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar 01; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 10. Enhanced amphetamine sensitivity and increased expression of dopamine D2 receptors in postpubertal rats after neonatal excitotoxic lesions of the medial prefrontal cortex.
    Flores G, Wood GK, Liang JJ, Quirion R, Srivastava LK.
    J Neurosci; 1996 Nov 15; 16(22):7366-75. PubMed ID: 8929443
    [Abstract] [Full Text] [Related]

  • 11. Combined intrastriatal dopamine D1 and serotonin 5-HT2 receptor stimulation reveals a mechanism for hyperlocomotion in 6-hydroxydopamine-lesioned rats.
    Bishop C, Walker PD.
    Neuroscience; 2003 Nov 15; 121(3):649-57. PubMed ID: 14568025
    [Abstract] [Full Text] [Related]

  • 12. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists.
    McPherson RJ, Marshall JF.
    Synapse; 2000 Jun 01; 36(3):194-204. PubMed ID: 10819899
    [Abstract] [Full Text] [Related]

  • 13. Role of dopamine D(4) receptors in motor hyperactivity induced by neonatal 6-hydroxydopamine lesions in rats.
    Zhang K, Tarazi FI, Baldessarini RJ.
    Neuropsychopharmacology; 2001 Nov 01; 25(5):624-32. PubMed ID: 11682245
    [Abstract] [Full Text] [Related]

  • 14. D1 priming enhances both D1- and D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats.
    Pollack AE, Thomas LI.
    Pharmacol Biochem Behav; 2010 Jan 01; 94(3):346-51. PubMed ID: 19800912
    [Abstract] [Full Text] [Related]

  • 15. Abnormal involuntary movement (AIM) expression following D2 dopamine agonist challenge is determined by the nature of prior dopamine receptor stimulation (priming) in 6-hydroxydopamine lesioned rats.
    Drake JD, Kibuuka LN, Dimitrov KD, Pollack AE.
    Pharmacol Biochem Behav; 2013 Apr 01; 105():26-33. PubMed ID: 23369985
    [Abstract] [Full Text] [Related]

  • 16. Dopamine agonists increase perseverative instrumental responses but do not restore habit formation in a rat model of Parkinsonism.
    Faure A, Leblanc-Veyrac P, El Massioui N.
    Neuroscience; 2010 Jun 30; 168(2):477-86. PubMed ID: 20362642
    [Abstract] [Full Text] [Related]

  • 17. Dopamine D1 receptor behavioral responsitivity following selective lesions of the striatal patch compartment during development.
    Neal BS, Joyce JN.
    Brain Res Dev Brain Res; 1991 Jun 21; 60(2):105-13. PubMed ID: 1832593
    [Abstract] [Full Text] [Related]

  • 18. Augmented sensitivity of D1-dopamine receptors in lateral but not medial striatum after 6-hydroxydopamine-induced lesions in the neonatal rat.
    Simson PE, Johnson KB, Jurevics HA, Criswell HE, Napier TC, Duncan GE, Mueller RA, Breese GR.
    J Pharmacol Exp Ther; 1992 Dec 21; 263(3):1454-63. PubMed ID: 1361576
    [Abstract] [Full Text] [Related]

  • 19. High frequency electro-acupuncture enhances striatum DAT and D1 receptor expression, but decreases D2 receptor level in 6-OHDA lesioned rats.
    Rui G, Guangjian Z, Yong W, Jie F, Yanchao C, Xi J, Fen L.
    Behav Brain Res; 2013 Jan 15; 237():263-9. PubMed ID: 23036843
    [Abstract] [Full Text] [Related]

  • 20. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
    Puschban Z, Scherfler C, Granata R, Laboyrie P, Quinn NP, Jenner P, Poewe W, Wenning GK.
    Neuroscience; 2000 Jan 15; 95(2):377-88. PubMed ID: 10658617
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.